Primary outcome reduced by anti-inflammatory drug in chronic coronary disease
Educational information
This video was recorded during the virtual congress of the ESC 2020.
Faculty
Mark Nidorf, MD - cardiologist, Perth, Australia
Disclosures
The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of EPCCS.
Read our summary of this trial
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: